Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)

Stryker (SYK) reported Liabilities and Shareholders Equity of $46.3 billion for Q1 2026, up 0.62% year-over-year from $46.0 billion in Q1 2025, and down 3.25% quarter-over-quarter from $47.8 billion in Q4 2025.

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $46.3 billion in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $46.3 billion, up 0.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $187.5 billion (up 9.06% YoY), and the FY2025 annual result was $47.8 billion, up 11.34% from the prior year.
  • Liabilities and Shareholders Equity declined to $46.3 billion in Q1 2026 per SYK's latest filing, from $47.8 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $47.8 billion in Q4 2025 and troughed at $36.0 billion in Q3 2022.
  • A 5-year average of $40.9 billion and a median of $39.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity gained 18.4% in 2025, then grew 0.62% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $36.9 billion in 2022, then climbed by 8.21% to $39.9 billion in 2023, then advanced by 7.66% to $43.0 billion in 2024, then gained by 11.34% to $47.8 billion in 2025, then declined by 3.25% to $46.3 billion in 2026.
  • Business Quant data shows SYK's Liabilities and Shareholders Equity at $46.3 billion in Q1 2026, $47.8 billion in Q4 2025, and $47.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 22.72 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.29 Bn
Dec 31, 2025 47.84 Bn
Sep 30, 2025 47.06 Bn
Jun 30, 2025 46.33 Bn
Mar 31, 2025 46.01 Bn
Dec 31, 2024 42.97 Bn
Sep 30, 2024 43.83 Bn
Jun 30, 2024 39.13 Bn
Mar 31, 2024 39.40 Bn
Dec 31, 2023 39.91 Bn
Sep 30, 2023 38.04 Bn
Jun 30, 2023 37.41 Bn
Mar 31, 2023 36.83 Bn
Dec 31, 2022 36.88 Bn
Sep 30, 2022 35.98 Bn
Jun 30, 2022 36.03 Bn
Mar 31, 2022 36.14 Bn
Dec 31, 2021 34.63 Bn
Sep 30, 2021 34.15 Bn
Jun 30, 2021 33.70 Bn